SR ONE CAPITAL MANAGEMENT, LP 13F Portfolio
| Entity | Category | QoQ AUM Change | AUM (13F) | # of Holdings | Performance Rank | Equities Trend |
|---|---|---|---|---|---|---|
SO SR ONE CAPITAL MANAGEMENT, LP | Institutional Filer | ▲ 29.60% | $915.4M | 14 |
Current Portfolio Holdings
Showing all 14 reported positions by value
| # | Stock | Company Name | Sector | Shares Held | Market Value | % of Portfolio |
|---|---|---|---|---|---|---|
| 1 | ACLX | Arcellx, Inc. | Healthcare | 2.3M | $269.4M | 29.43% |
| 2 | MANE | Veradermics, Inc. | — | 2.4M | $151.7M | 16.57% |
| 3 | ZBIO | Zenas BioPharma, Inc. | Healthcare | 5.0M | $98.5M | 10.76% |
| 4 | CRSP | CRISPR Therapeutics AG | Healthcare | 2.0M | $97.0M | 10.59% |
| 5 | DSGN | Design Therapeutics, Inc. | Healthcare | 6.5M | $69.4M | 7.59% |
| 6 | ORIC | ORIC Pharmaceuticals, Inc. | Healthcare | 4.5M | $58.5M | 6.39% |
| 7 | ALMS | Alumis Inc. Common Stock | Healthcare | 2.0M | $43.2M | 4.72% |
| 8 | MLYS | Mineralys Therapeutics, Inc. | Healthcare | 1.6M | $42.4M | 4.63% |
| 9 | SPRY | ARS Pharmaceuticals, Inc. | Healthcare | 4.0M | $32.2M | 3.52% |
| 10 | ORKA | Oruka Therapeutics, Inc. | Healthcare | 430K | $21.1M | 2.31% |
| 11 | OCS | Oculis Holding AG | Healthcare | 641K | $17.0M | 1.86% |
| 12 | NKTX | Nkarta, Inc. | Healthcare | 3.3M | $7.0M | 0.77% |
| 13 | ENGN | enGene Holdings Inc. | Healthcare | 748K | $5.1M | 0.56% |
| 14 | RARE | Ultragenyx Pharmaceutical Inc. | Healthcare | 138K | $2.9M | 0.32% |
Showing 1 to 14 of 14 holdings